O'Neill: UK 'Lost Focus' On Antibiotic Crisis And Pharma Must Do More
Executive Summary
The time for talking is over when it comes to antimicrobial resistance, says Jim O'Neill, urging the government to 'rediscover the passion for championing' initiatives in the UK, notably the new AMR Centre in Alderley Park near Manchester.
You may also be interested in...
New Report Calls For Pushing And Pulling In Global Fight Against Superbugs
New DRIVE-AB report on revitalizing antibiotic R&D suggests market-entry rewards of up to $1bn for companies introducing novel products, cites need for increasing public funding of R&D support.
O'Neill Warns Pharma Risks Backlash If Doesn't Engage In World AMR Pact
The globalized drugs industry needs to play ball and help find a solution to antimicrobial resistance or risk getting blamed for its failure and the resulting world health crisis.
Bayer Banks On Boston To Achieve Oncology Ambitions
The German major is investing heavily in cancer R&D and has opened the doors of a new facility in the biotech epicenter on the east coast of the US.